PAPER Koistinaho J, Malm T, Goldsteins G
SEARCH RESULTS
331254 RESULTS
PAPER Srinivasan V, Spence DW, Pandi-Perumal SR, Brown GM, Cardinali DP
Melatonin in mitochondrial dysfunction and related disorders.
Int J Alzheimers Dis. 2011;2011:326320. PubMed: 21629741PAPER Vecchio F, Määttä S
The use of auditory event-related potentials in Alzheimer's disease diagnosis.
Int J Alzheimers Dis. 2011;2011:653173. PubMed: 21629759PAPER Rodriguez G, Arnaldi D, Picco A
Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring.
Int J Alzheimers Dis. 2011;2011:481903. PubMed: 21629749PAPER Julkunen P, Jauhiainen AM, Könönen M, Pääkkönen A, Karhu J, Soininen H
Combining transcranial magnetic stimulation and electroencephalography may contribute to assess the severity of Alzheimer's disease.
Int J Alzheimers Dis. 2011;2011:654794. PubMed: 21629763PAPER Moreno H, Choi S, Yu E, Brusco J, Avila J, Moreira JE, Sugimori M, Llinás RR
Blocking Effects of Human Tau on Squid Giant Synapse Transmission and Its Prevention by T-817 MA.
Front Synaptic Neurosci. 2011;3:3. PubMed: 21629767PAPER Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
Mol Med. 2011 Sep-Oct;17(9-10):974-9. PubMed: 21629967PAPER Chianella C, Gragnaniello D, Delser PM, Visentini MF, Sette E, Tola MR, Barbujani G, Fuselli S
BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
Eur J Clin Pharmacol. 2011 Nov;67(11):1147-57. PubMed: 21630031PAPER Cui W, Sun Y, Wang Z, Xu C, Xu L, Wang F, Chen Z, Peng Y, Li R
Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels.
Neurochem Res. 2011 Oct;36(10):1910-21. PubMed: 21630010PAPER During EH, Osorio RS, Elahi FM, Mosconi L, de Leon MJ
The concept of FDG-PET endophenotype in Alzheimer's disease.
Neurol Sci. 2011 Aug;32(4):559-69. PubMed: 21630036PAPER Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM
Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
Acta Neuropathol. 2011 Sep;122(3):285-92. PubMed: 21630115PAPER Moh C, Kubiak JZ, Bajic VP, Zhu X, Smith MA, Lee HG
Cell cycle deregulation in the neurons of Alzheimer's disease.
Results Probl Cell Differ. 2011;53:565-76. PubMed: 21630160PAPER López-Sánchez N, Ovejero-Benito MC, Borreguero L, Frade JM
Control of neuronal ploidy during vertebrate development.
Results Probl Cell Differ. 2011;53:547-63. PubMed: 21630159PAPER Andreetto E, Yan LM, Caporale A, Kapurniotu A
Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity.
Chembiochem. 2011 Jun 14;12(9):1313-22. PubMed: 21630409PAPER Doody RS, Ferris SH, Salloway S, Meuser TM, Murthy AK, Li C, Goldman R
Identifying amnestic mild cognitive impairment in primary care: a feasibility study.
Clin Drug Investig. 2011;31(7):483-91. PubMed: 21627337Current Filters
No filters selected